Cargando…
Immunotherapeutic Activities of a DNA Plasmid Carrying the Mycobacterial hsp65 Gene (DNAhsp65)
DNA vaccines have become relevant subject matter, and efforts for their development have been increasing due to their potential as technology platforms applicable for prophylactic and therapeutic approaches for infectious diseases and for cancer treatment, allergies, and autoimmune diseases. This re...
Autores principales: | Silva, Celio Lopes, Malardo, Thiago, Tahyra, Aline Seiko Carvalho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757890/ https://www.ncbi.nlm.nih.gov/pubmed/35047886 http://dx.doi.org/10.3389/fmedt.2020.603690 |
Ejemplares similares
-
BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2013) -
DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes
por: Santos, Rubens R, et al.
Publicado: (2009) -
Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases
por: Zhang, Peilin, et al.
Publicado: (2019) -
New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro
por: Pileggi, Gecilmara Salviato, et al.
Publicado: (2016) -
Reliable identification of mycobacterial species by PCR-restriction enzyme analysis (PRA)-hsp65 in a reference laboratory and elaboration of a sequence-based extended algorithm of PRA-hsp65 patterns
por: Chimara, Erica, et al.
Publicado: (2008)